Visit and Join the WeHeal Chronic Myelogenous Leukemia Community.
For more information, see: Mayo Clinic | Wikipedia
Clinical Trials: Clinicaltrials.gov | In Clinical Trials | EU Clinical Trials Register | WeHeal Guide to Researching Clinical Trials
Chronic Myelogenous Leukemia (CML) – this a type of cancer of the blood cells. The term “chronic” indicates that this cancer tends to progress more slowly than acute forms of leukemia. The term “myelogenous” refers to the type of cells affected by this cancer (red blood cells).
The “Philadelphia Chromosome” is the nickname given to the cell mutation that most often causes CML. This mutation can cause other forms of leukemia as well, including ALL or Acute Lymphoblastic leukemia. A Kinase Inhibitor drug developed by Novartis Pharmaceuticals called “Gleevec”or Imatinib, has been so effective that many CML patients control their disease with one pill a day with little side effects.
Visit and Join the WeHeal Chronic Myelogenous Leukemia Community.
For more information, see: Mayo Clinic | Wikipedia
WeHeal is very grateful to our valued sources of information which include Wikipedia, WebMD, ClinicalTrials.gov, Cancer.gov, Infoplease, and the US CDC (Center for Disease Control).